OCUL
Ocular Therapeutix Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$8.76
-0.11 ▼ -1.24%
🌙 3월 13일 7:57 PM ET (한국 3/14 08:57)
$8.60
-0.16 ▼ -1.83%
| Index | RUT | P/E | - | EPS (ttm) | -1.44 | Insider Own | 9.57% | Shs Outstand | 0.22B | Perf Week | -14.7% |
| Market Cap | 1.91B | Forward P/E | - | EPS next Y | 7.33% | Insider Trans | -1.05% | Shs Float | 0.20B | Perf Month | -4.37% |
| Enterprise Value | 1.25B | PEG | - | EPS next Q | -0.32 | Inst Own | 83.34% | Short Float | 8.96% | Perf Quarter | -43.15% |
| Income | -0.27B | P/S | 36.71 | EPS this Y | 4.9% | Inst Trans | 4.28% | Short Ratio | 2.83 | Perf Half Y | -31.4% |
| Sales | 0.05B | P/B | 2.89 | EPS next 5Y | 11.99% | ROA | -41.91% | Short Interest | 17.65M | Perf YTD | -27.84% |
| Book/sh | 3.03 | P/C | 2.59 | EPS past 3/5Y | -15.4% 11.13% | ROE | -54.85% | 52W High | -46.72% ($16.44) | Perf Year | 11.17% |
| Cash/sh | 3.39 | P/FCF | - | Sales past 3/5Y | 0.29% 24.45% | ROIC | -36.51% | 52W Low | 51.03% ($5.80) | Perf 3Y | 74.5% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -14.01% | Gross Margin | 87.35% | Volatility(W/M) | 5.72% 8.33% | Perf 5Y | -57.97% |
| Dividend TTM | - | EV/Sales | 24 | Sales Y/Y TTM | -18.47% | Oper. Margin | -519.75% | ATR (14) | 0.74 | Perf 10Y | 3.91% |
| Dividend Ex-Date | - | Quick Ratio | 15.32 | EPS Q/Q | -0.69% | Profit Margin | -511.9% | RSI (14) | 42.66 | Recom | 1.08 |
| Dividend Gr. 3/5Y | - | Current Ratio | 15.39 | Sales Q/Q | -22.43% | SMA20 | -4.41% ($9.16) | Beta | 0.94 | Target Price | $26.31 |
| Payout | - | Debt/Eq | 0.12 | Earnings | 2000000 | SMA50 | -11.56% ($9.91) | Rel Volume | 0.6 | Prev Close | $8.87 |
| Employees | 325 | LT Debt/Eq | 0.11 | EPS/Sales Surpr. | 9.63% -17.85% | SMA200 | -21.24% ($11.12) | Avg Volume(3M) | 6.23M | Price | $8.76 |
| IPO | 2014/7/25 | Option/Short | Yes/Yes | Trades | 18909 | Volume | 3,725,201 | Change | -1.24% |
뉴스 로딩 중...